DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Tyrosine Protein Kinase JAK3 (Janus Kinase 3 or Leukocyte Janus Kinase or JAK3 or EC 188.8.131.52) - Pipeline Review, H2 2016" drug pipelines to their offering.
This report provides comprehensive information on the therapeutic development for Tyrosine Protein Kinase JAK3, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Tyrosine Protein Kinase JAK3 and special features on late-stage and discontinued projects.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.
Key Topics Covered:
- Tyrosine Protein Kinase JAK3 Overview
- Therapeutics Development
- Pipeline Products for Tyrosine Protein Kinase JAK3 - Overview
- Pipeline Products for Tyrosine Protein Kinase JAK3 - Comparative Analysis
- Tyrosine Protein Kinase JAK3 - Therapeutics under Development by Companies
- Tyrosine Protein Kinase JAK3 - Therapeutics under Investigation by Universities/Institutes
- Tyrosine Protein Kinase JAK3 Products Glance
- Late Stage Products
- Clinical Stage Products
- Early Stage Products
- Tyrosine Protein Kinase JAK3 - Products under Development by Companies
- Tyrosine Protein Kinase JAK3 - Products under Investigation by Universities/Institutes
- Tyrosine Protein Kinase JAK3 - Companies Involved in Therapeutics Development
- Aclaris Therapeutics, Inc.
- Advinus Therapeutics Ltd
- Arrien Pharmaceuticals, LLC
- Astellas Pharma Inc.
- Bristol-Myers Squibb Company
- Chipscreen Biosciences Ltd
- Creabilis SA
- F. Hoffmann-La Roche Ltd.
- Ligand Pharmaceuticals, Inc.
- MYOS RENS Technology Inc.
For more information about this drug pipelines visit http://www.researchandmarkets.com/research/4t6m2k/tyrosine_protein
Related Topics: Enzymes